Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase
Observational
Started
2026-03-01
Last updated
2026-04-01
Condition(s) studied
Thyroid Nodule
Investigational drug(s) / intervention(s)
Histopathology or cytopathology.
Histopathology or cytopathology.: This is a observation stufy.
Study summary
The prospective study aim to develop a multimodal deep learning model that integrates ultrasound images and cytological whole-slide images for more accurate malignant risk prediction of Bethesda III thyroid nodules.
Eligibility
Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria:
* (a) Patients who underwent fine-needle aspiration of thyroid nodules and received a cytological diagnosis of Bethesda Ⅲ.
* (b) Patients who subsequently underwent thyroid surgery with a definitive histopathological diagnosis of benign or malignant lesions,.
* (c) Availability of at least one ultrasound image acquired prior to surgery.
Exclusion Criteria:
* (a) Patients without confirmation by surgical pathology,.
* (b) Patients without any available or usable ultrasound images.
Primary outcome measure(s)
Pathological diagnosis. — One month after the surgery. WHO guidelines.
Trial sites (1)
Facility
City
Region
Status
No. 33 Yingfeng Road, Haizhu District, Guangzhou City, Guangdong Province, Sun Yat-sen Memorial Hospital
Guangzhou
Guangzhou
Recruiting
More Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.